CCR5 antagonists such as MVC are not recommended for patients infected with X4-tropic HIV-1.3 Thus, alternative therapy should be considered if the net tropism assessment result is ???DM/X4.??? A net tropism assessment of ???R5??? is consistent with eligibility for treatment with a CCR5 antagonist.